Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint TherapyKathrin Renner, Marina Kreutz, Holger M. Becker et al.|Cell Reports|2019Cited by 297
New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor CellsEva Gottfried, Marina Kreutz|PLoS ONE|2013Cited by 118